News

Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
Recursion (NASDAQ: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives today announced the acquisition of Rallybio’s (NASDAQ: RLYB) full interest in their joint ...
AZoOptics14d
Using ATR-IR Spectroscopy for Real-Time Liver Tumor Diagnosis During Surgery
Fiber-optic ATR-IR spectroscopy enables real-time liver tumor classification during surgery, offering faster and more objective diagnostics with machine learning support.
AZoBuild on MSN18d
AI Model Identifies Greener Cement Mixes Without Compromising Strength
Innovative AI techniques in cement formulation lead to eco-friendly mixes, significantly cutting emissions and improving efficiency in construction materials.
DISABLED ENTREPRENEUR UK on MSN18h
Can We Upload Our Consciousness?
For centuries, humanity has been fascinated with the idea of immortality, whether spiritual, biological, or digital. With ...
Recursion Pharmaceuticals: Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
Recursion (NASDAQ: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives today announced the acquisition of ...
Daily News14d
BagelTechNews.com Reveals Shocking Tech Trends You Must Know
If you think you’ve seen all the latest tech trends 2024 out there, think again. BagelTechNews.com reveals some seriously shocking tech trends you must know ...